Consortium Costs Debated As BARDA, Industry Discuss Plans For Next Pandemic Response
Executive Summary
BARDA’s consortium approach scrutinized as industry recovers from US Defense Production Act rated orders. Questions of sustainment fees, interruptible commercial activities explored during BioMaC Industry Day call as agency emphasizes need for proven capacity.